Overtraining Syndrome: Causes, Diagnosis, and What's Actually Going On

Why It Matters

Mislabeling athletes as overtrained can mask treatable medical conditions and trigger nocebo effects that worsen performance, making accurate diagnosis and evidence‑based training adjustments critical for health and competitive success.

Key Takeaways

• Overtraining syndrome lacks controlled experimental evidence confirming its existence.
• The term “overtraining” is used inconsistently across fields.
• Diagnosis requires exclusion of common medical conditions like anemia.
• Labeling athletes “overtrained” can induce nocebo effects, impairing performance.
• Research should focus on underlying biology rather than the syndrome label.

Summary

The Barbell Medicine podcast episode tackles the murky concept of overtraining syndrome, highlighting that despite its ubiquity in coaching manuals, wearable dashboards and sports‑medicine literature, no controlled experimental study has ever documented a healthy athlete transitioning into a true overtrained state. A 2022 systematic review found zero qualifying trials, underscoring that the syndrome rests on retrospective observations rather than rigorous proof.

The hosts dissect why the term is so problematic: it serves at least four distinct roles—from a deliberate overreaching stimulus to a feared pathological failure—depending on the audience. In clinical contexts it is a diagnosis of exclusion, requiring clinicians to rule out anemia, thyroid disorders, low‑energy availability and other common conditions before applying the label. Meanwhile, coaches and algorithms often misuse the word, and the resulting mislabeling can trigger powerful nocebo effects, with recent meta‑analyses showing negative expectations doubling the performance decrement compared to placebo.

Memorable moments include Dr. Vagenbomb’s warning that “naming a pattern is not the same as identifying a disease” and Dr. Brocky’s explanation of how nocebo mechanisms operate through neuro‑biological pathways similar to placebo. The discussion also cites a systematic review finding that nocebo effects in sport are roughly twice as large as placebo effects, illustrating how language alone can alter physiology.

The takeaway for athletes, coaches and sports‑medicine practitioners is clear: avoid reflexively blaming training load, first screen for more prevalent medical issues, and recognize that the overtraining label may obscure the true underlying cause. Future research should shift from chasing a vague syndrome to elucidating the specific biological stressors and recovery pathways that drive performance loss.

Original Description

In 2022, researchers conducted the most rigorous systematic review ever performed on overtraining syndrome — looking specifically for controlled studies that documented a human transitioning from a healthy training state to an overtrained state. Zero studies met those criteria.

The word "overtrained" appears in coaching certifications, wearable device dashboards, and clinical sports medicine guidelines — and in each context it means something different. That definitional chaos has consequences: it delays real diagnoses, produces nocebo effects with measurable physiological outcomes, and leads athletes to reduce training they didn't need to reduce.

In this episode, Drs. Jordan Feigenbaum and Austin Baraki work through the full evidence base on overtraining syndrome — the taxonomy, the attempted studies, the six competing mechanistic theories, the biomarker failures, and what's actually happening when a lifter can't make progress.

Timestamps:

• 0:00 Cold open — the zero-studies finding

• 1:21 Why "overtrained" does four different jobs simultaneously

• 16:10 The FOR / NFOR / OTS taxonomy

• 19:43 The supercompensation model — borrowed from endurance, never validated for resistance training

• 32:28 Austin's clinical differential for fatigue and declining performance

• 36:17 RT evidence — what happens when researchers try to induce OTS through lifting

• 43:19 Austin — what actually drives the complaints he sees in practice

• 47:30 Six theories for what causes overtraining syndrome

• 1:01:09 The biomarker problem — why the T:C ratio and cortisol don't work

• 1:05:09 What your wearable is actually measuring (and what it isn't)

• 1:09:28 Austin — testosterone levels in trained athletes and when to act

• 1:13:40 Heart rate variability — limitations for strength training

• 1:15:36 Session RPE — the monitoring tool that actually works

• 1:17:31 How common is overtraining syndrome, really?

• 1:23:04 Three failure modes — what's actually happening when lifters say they feel overtrained

• 1:32:14 Austin — what a proper medical workup looks like

• 1:34:22 Outro

What we cover:

• The definition problem — why a single word is doing four incompatible jobs simultaneously, and why that matters clinically and practically.

• The taxonomy — functional overreaching, nonfunctional overreaching, and overtraining syndrome as points on a continuous variable that can only be identified after the fact, not at presentation.

• The supercompensation model — where it came from, why it fails to describe how resistance training adaptation actually works, and how applying it too literally produces both overloading and underloading errors at the same time.

• Austin's clinical differential — what a physician actually works through when a patient presents with fatigue and declining performance, and where overtraining syndrome actually sits on that list.

• What resistance training research shows — including 140 maximal singles, 90 working sets per week, and daily 1-rep max attempts. No study has cleanly induced overtraining syndrome through resistance training. The hormonal data went in the opposite direction from what the endurance overtraining model predicts.

• Six mechanistic theories — glycogen depletion, serotonin/BCAA, autonomic imbalance, central governor, HPA axis dysregulation, and Armstrong's complex systems framework. Each one is partially supported and each falls short.

• The biomarker problem — resting cortisol is normal in 75%+ of OTS cases, the testosterone to cortisol ratio has never been validated against clinical outcomes as an individual diagnostic, and HRV recovery in strength training lags physical recovery by up to 30 hours.

• Austin on wearables — including a clinical pattern he's seeing with GLP-1 receptor agonists: wearable scores indicating deterioration when the clinical picture is actually fine.

• Session RPE as the real tool — why session RPE trending upward at stable training load is a more reliable signal of load-recovery mismatch than any biomarker currently used.

• Prevalence and confounders — the 60% figure, why it almost certainly captures all three FOR/NFOR/OTS categories plus REDS, depression, and illness, and why the residual true training-load-induced OTS in an otherwise healthy athlete may be vanishingly rare.

• Three failure modes — the three things Jordan actually sees in practice when lifters present saying they feel overtrained, and how to distinguish between them using session RPE.

• The medical workup — Austin's practical walkthrough of what to assess when programming and lifestyle changes don't move the needle, including iron deficiency (ferritin testing caveats, lab reference range problems), sleep apnea, post-viral syndromes, and hormone panels done correctly.

Next Steps:

For evidence-based resistance training programs: barbellmedicine.com/training-programs

For individu...